Insmed (INSM) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $125.77 +0.55%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.95), $0.05 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $50.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
